UPC
ONC

Utah Peaks Capital’s BeOne Medicines Ltd ONC Stock Holding History

Utah Peaks Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,300
Closed -$3.3M – 21
2023
Q1 		$3.3M Buy
+15,300
New +$3.67M 4.37% 8

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Utah Peaks Capital's ONC Position: Q2 2023 in Review

Utah Peaks Capital sold out of BeOne Medicines Ltd (ONC) in Q2 2023, closing a stake of 15,300 shares — an estimated $3.3M sold.

Utah Peaks Capital first reported a position in ONC in Q1 2023 and held it in 1 quarter. The position peaked at $3.3M in Q1 2023. 209 funds tracked by Wall St. Rank hold ONC as of Q2 2023.

  • Utah Peaks Capital reported no remaining BeOne Medicines Ltd position as of Q2 2023 after selling out during the quarter.
  • Utah Peaks Capital sold 15,300 BeOne Medicines Ltd shares in Q2 2023, an estimated $3.3M.
  • Utah Peaks Capital first reported a position in BeOne Medicines Ltd in Q1 2023 and held it in 1 quarter.
  • Utah Peaks Capital's BeOne Medicines Ltd position peaked at $3.3M in Q1 2023.
  • 209 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.

Based on Utah Peaks Capital's 13F filing for Q2 2023.